Moreover, similar to HIF-1, AK4 has been shown to promote chemotherapeutic resistance in tumors and is regarded as an unfavorable prognostic marker for tumor metastasis and lung cancer patient outcomes [37,39,40,41,42]. This evidence concerns the gene HIF1A and lung carcinoma.